A FAP vaccine using a modified vaccinia Ankara vector combined with cyclophosphamide also significantly enhanced anti-tumor immune response decreased Tregs infiltration, and prolonged the survival of 4T1 tumor-bearing mice [229]. The gene discussed is FAP; the disease is neoplasm.